A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients With Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum
This study compares two different treatment plans for a slow-growing type of cancer that starts in the ovaries, fallopian tubes, or nearby areas. Researchers want to find out if using hormone therapy along with standard chemotherapy works better than hormone therapy alone.
You may be able to join if you have a recent diagnosis of stage II, III, or IV low-grade serous cancer in the ovaries, fallopian tubes, or lining of the abdomen. You must not have received any prior chemotherapy, radiation, or hormone therapy for this condition.
Participants will be placed into one of the treatment groups to receive either chemotherapy drugs like paclitaxel and carboplatin, hormone therapy with letrozole, or a combination of both. You will also have regular check-ups, scans, and tissue sample collections to monitor your health and how the treatment is working.
This study has locations including Anchorage, Alaska, and is currently active but not looking for new participants.
- 1Tests different combinations of chemotherapy and hormone therapy for specific ovarian and abdominal cancers.
- 2Designed for patients who have not yet received any treatment for this specific diagnosis.
- 3The main goal is to see which treatment approach controls tumor growth the best.
Related video
Related links
Outside pages about this study, checked by our team
This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.